scispace - formally typeset
Search or ask a question

Showing papers by "Andrew P. Holmes published in 2017"

Journal Article•DOI•
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial

[...]

Courtney Crim1, Peter M.A. Calverley2, Julie A. Anderson, Andrew P. Holmes, Sally Kilbride, Fernando J. Martinez3, Robert D. Brook4, David E. Newby5, Julie C. Yates1, Bartolome R. Celli6, Jørgen Vestbo7, Summit investigators •
Research Triangle Park1, University of Liverpool2, Cornell University3, University of Michigan4, University of Edinburgh5, Brigham and Women's Hospital6, University Hospital of South Manchester NHS Foundation Trust7
01 Oct 2017-Respiratory Medicine
TL;DR: In contrast to previous studies in patients with severe disease, increased pneumonia risk with inhaled corticosteroid use was not evident in COPD subjects with moderate airflow limitation and heightened cardiovascular risk.

28 citations